Whose Values In Adolescent Health- Adults Or Adolescents?

Published Jun 17, 2012
Adelaide, South Australia – Differences between adolescents and adult values for assessing the health benefits of new medical interventions may be significant enough to impact upon health care policy. An on-line survey including two health status instruments, the CHU9D and the AQOL-6D was developed for administration to adolescents living in Australia, aged 11-17 years (n=500). Individual responses to both instruments were converted to values by applying firstly the adult and secondly the adolescent scoring algorithms for each instrument. Both instruments discriminated well according to current health status and the presence of long standing illness regardless of the scoring algorithm employed. Important differences, however, between adolescent and adult values were found, these being more profound for the CHU9D. This study, “Whose Values in Health? An Empirical Comparison of the Application of Adolescent and Adult Values for the CHU9D and AQOL-6D in the Australian Adolescent General Population,” will appear in a future issue of Value in Health, and was co-authored by Julie Ratcliffe from Flinders University, Katherine Stevens and John Brazier from the University of Sheffield, Terry Flynn from the University of Technology Sydney and Michael Sawyer from the University of Adelaide. Says Professor Ratcliffe, “We have utilised a community based sample of adolescents to highlight potentially important differences in adult and adolescent values for identical health states. Ultimately these differences could significantly impact upon the results of studies to assess the cost effectiveness of new medical interventions targeted for adolescents.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Launches New Content on Whole Health

Sep 23, 2025

ISPOR announced that it has launched new website content on whole health, a topic of increasing importance as health systems across the globe grapple with providing the best possible healthcare to patients within constrained budgets.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×